Neurxstem has developed a patented synthetic Neural Organoid Platform that is a synthetic mimic of the human central nervous system. It is a novel, first in class platform for studying human brain disease mechanisms and drug discovery, efficacy and safety testing.
“A Harvard medical pioneer calls it “astounding” — an “incredible achievement” and a “quantum leap forward” in the battle against cancer, autism, Parkinson’s and Alzheimer’s” - CNN
“It is an extraordinary technological feat” - BBC